Deciphera Pharmaceuticals, Inc. Proceeds from Stock Options Exercised
Deciphera Pharmaceuticals, Inc. reported Proceeds from Stock Options Exercised of $2.87 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2024-02-07
- Deciphera Pharmaceuticals, Inc. proceeds from stock options exercised for the quarter ending 2021-03-31 was $936.00K, a 63.57% decline year-over-year.
- Deciphera Pharmaceuticals, Inc. proceeds from stock options exercised for the quarter ending 2020-12-31 was $9.76M, a 347.34% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. proceeds from stock options exercised for the quarter ending 2020-09-30 was $3.23M, a 30.37% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. proceeds from stock options exercised for the quarter ending 2020-06-30 was $4.83M, a 5859.26% increase year-over-year.
- Deciphera Pharmaceuticals, Inc. proceeds from stock options exercised for fiscal 2023 was $2.87M, a 75.67% increase from fiscal 2022.
- Deciphera Pharmaceuticals, Inc. proceeds from stock options exercised for fiscal 2022 was $1.63M, a 74.26% decline from fiscal 2021.
- Deciphera Pharmaceuticals, Inc. proceeds from stock options exercised for fiscal 2021 was $6.34M, a 68.89% decline from fiscal 2020.
- Deciphera Pharmaceuticals, Inc. proceeds from stock options exercised for fiscal 2020 was $20.39M, a 246.21% increase from fiscal 2019.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2023-12-31 | $2.87M 10-K · filed 2024-02-07 | |||
| 2022-12-31 | $1.63M 10-K · filed 2024-02-07 | |||
| 2021-12-31 | $6.34M 10-K · filed 2024-02-07 | |||
| 2021-03-31 | $936.00K 10-Q · filed 2021-05-04 | $10.70M derived: sum of 2 quarters · filed 2023-02-07 | $13.93M derived: sum of 3 quarters · filed 2023-02-07 | $18.75M derived: sum of 4 quarters · filed 2023-02-07 |
| 2020-12-31 | $9.76M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $12.99M derived: sum of 2 quarters · filed 2023-02-07 | $17.82M derived: sum of 3 quarters · filed 2023-02-07 | $20.39M 10-K · filed 2023-02-07 |
| 2020-09-30 | $3.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $8.05M derived: sum of 2 quarters · filed 2020-11-05 | $10.62M 10-Q · filed 2020-11-05 | $12.81M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-06-30 | $4.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $7.40M 10-Q · filed 2020-08-04 | $9.58M derived: sum of 3 quarters · filed 2022-02-08 | $12.05M derived: sum of 4 quarters · filed 2022-02-08 |
| 2020-03-31 | $2.57M 10-Q · filed 2021-05-04 | $4.75M derived: sum of 2 quarters · filed 2022-02-08 | $7.23M derived: sum of 3 quarters · filed 2022-02-08 | $7.31M derived: sum of 4 quarters · filed 2022-02-08 |
| 2019-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-08 | $4.66M derived: sum of 2 quarters · filed 2022-02-08 | $4.74M derived: sum of 3 quarters · filed 2022-02-08 | $5.89M 10-K · filed 2022-02-08 |
| 2019-09-30 | $2.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $2.56M derived: sum of 2 quarters · filed 2020-11-05 | $3.71M 10-Q · filed 2020-11-05 | $3.81M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-06-30 | $81.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $1.23M 10-Q · filed 2020-08-04 | $1.34M derived: sum of 3 quarters · filed 2021-02-09 | $1.43M derived: sum of 4 quarters · filed 2021-02-09 |
| 2019-03-31 | $1.15M 10-Q · filed 2020-05-05 | $1.26M derived: sum of 2 quarters · filed 2021-02-09 | $1.35M derived: sum of 3 quarters · filed 2021-02-09 | $2.05M derived: sum of 4 quarters · filed 2021-02-09 |
| 2018-12-31 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-09 | $198.00K derived: sum of 2 quarters · filed 2021-02-09 | $905.00K derived: sum of 3 quarters · filed 2021-02-09 | $915.00K 10-K · filed 2021-02-09 |
| 2018-09-30 | $91.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-04 | $798.00K derived: sum of 2 quarters · filed 2019-11-04 | $808.00K 10-Q · filed 2019-11-04 | |
| 2018-06-30 | $707.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-02 | $717.00K 10-Q · filed 2019-08-02 | ||
| 2018-03-31 | $10.00K 10-Q · filed 2019-05-09 | |||
| 2017-12-31 | $0.00 10-K · filed 2020-03-09 |